IgA-nefropátia: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• BCMA 7
• CD19 8
• SGLT2 1
• CD20 0
• CD38 0
• IL-6 0
• JAK 0
• NLRP3 0
• TLR4 0
• mTOR 0
• STING 0
• IL-17 0
• AKT 0
• AMPK 0
• EGFR 0
• FAK 0
• GPX4 0
• HER2 0
• IL-1 0
• MET 0
• MYC 0
• NRF2 0
• PD-1 0
• PI3K 0
• STAT3 0
• TP53 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIDDK · R01

  Determination of structural features critical for nephritogenic properties of IgA1-containing immune complexes in IgA nephropathy

  University of Alabama at Birmingham· Birmingham, Egyesült Államok· 743 278 USD awarded in fiscal year 2026· until 2030. máj.

• NIH NIDDK · R01

  Dapagliflozin in Active Lupus Nephritis: A Pilot and Feasibility Randomized Trial

  Brigham and Women's Hospital· Boston, Egyesült Államok· 364 560 USD awarded in fiscal year 2026· until 2028. dec.

• NIH NIDDK · F32

  The Impact of APOL1 Copy Number Variation on Kidney Disease Susceptibility in African Americans

  Beth Israel Deaconess Medical Center· Boston, Egyesült Államok· 79 348 USD awarded in fiscal year 2026· until 2027. aug.

• NIH NIDDK · R01

  Interrogating The Biology Of Human Lupus Nephritis Using Single Cell Resolution Spatial Transcriptomics

  Seattle Children's Hospital· Seattle, Egyesült Államok· 801 241 USD awarded in fiscal year 2026· until 2028. jan.

• NIH NIAID · R01

  Contributions of autophagy-related genes in lupus

  Oklahoma Medical Research Foundation· Oklahoma City, Egyesült Államok· 751 755 USD awarded in fiscal year 2026· until 2027. júl.

• European Commission (Horizon Europe) · HORIZON-ERC

  Role of CD1c-reactive T cells and lipid antigens in post-streptococcal disease (CReativeLipid)

  The Chancellor, Masters and Scholars of the University of Oxford· Oxford, Egyesült Királyság· EU contribution 1 491 316 EUR· until 2030. szept.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Antigen-specific treatments to target autoimmune kidney diseases (AUTO-TARGET)

  Universitaetsklinikum Hamburg-Eppendorf· Hamburg, Németország· EU contribution 1 499 663 EUR· until 2030. márc.

• European Commission (Horizon Europe) · HORIZON-RIA

  Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology (geneTIGA)

  Charite - Universitaetsmedizin Berlin· Berlin, Németország· EU contribution 6 393 734 EUR· until 2026. dec.· 8 countries

8 of 22 running projects, newest first. Listed amounts together: 11,1 M USD + 9,4 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 6
• Mendelian Randomization Analysis 14
• Gene Expression Profiling 14
• Proteomics 8
• Metabolomics 5
• Flow Cytometry 2
• Immunohistochemistry 4
• Magnetic Resonance Imaging 1
• Machine Learning 9
• Deep Learning 3
• Cohort Studies 14
• Genome-Wide Association Study 20

• Cross-phenotype integration of eQTL-based Mendelian randomization and transcriptomics prioritizes BMP2K in IgA vasculitis with nephritis.

  Front Immunol, 2026. szept.

• Identification of key genes related to arginine metabolism in immunoglobulin A nephropathy through the combination of scRNA-seq and bulk RNA-seq data.

  Front Immunol, 2026. aug.

• Shared genetics of IgA nephropathy and cardiometabolic diseases revealed by integrative genomic analysis.

  Ren Fail, 2026. júl.

• Spatial transcriptomic profiling reveals molecular signatures of endocapillary hypercellularity in IgA nephropathy.

  BMC Nephrol, 2026. júl.

• Spatially microdissected profiling of tonsillar germinal centers reveals a KLRG1-enriched immune signature in IgA nephropathy.

  Front Immunol, 2026. máj.

• Identification of pyroptosis-related hub genes and immune cell infiltration in IgA nephropathy via bioinformatics analysis.

  Ren Fail, 2026. máj.

• A nine-gene diagnostic model for IgA nephropathy based on multi-cohort machine learning: integrating gene expression and immunohistochemical validation.

  Ren Fail, 2026. márc.

• Identifying the hub genes in macrophage infiltration and verifying of the role of VSIG4 in IgA nephropathy.

  Sci Rep, 2026. febr.

• The shared mechanisms and potential diagnostic markers for IgA nephropathy and celiac disease.

  Autoimmunity, 2026. febr.

• Identification of ubiquitination-related signature genes for predicting kidney transplant rejection.

  Sci Rep, 2026. febr.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.